decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Appendix E - National Coverage Determinations Manual / CHEMICALAVERSION_THERAPY_FOR_TREATMENT_OF_ALCOHOLISM
Subscribe or sign in to view the full article.
Article Overview
This article explains the Medicare coverage framework for chemical aversion therapy in the treatment of alcoholism. It discusses the therapy’s general purpose, the types of treatment programs it may be part of, and the circumstances under which inpatient or outpatient care considerations may arise. The content is relevant to coders, billers, utilization review staff, and clinicians working with Medicare coverage policy and medical necessity documentation.
Why This Topic Matters
It helps readers understand how CMS addresses coverage and medical necessity for this behavioral treatment approach, including the role of physician certification and level-of-care considerations.
What You Will Learn
- The Medicare coverage context for chemical aversion therapy in alcoholism treatment
- How the article frames medical necessity and physician certification
- What the article says about inpatient versus outpatient treatment settings
- The role of coverage policy and review entities in determining appropriateness of care
Who Should Read This
- Medical coders
- Billing staff
- Utilization review staff
- Compliance professionals
- Physicians
- Behavioral health clinicians
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com